Efficacy and Tolerability of Dolutegravir-Based Dual-Therapies in HIV Naive and Switch Patients

Jose Manuel Vinuesa-Hernando*; Galadriel Pellejero-Sagastizabal; Mercedes Gimeno-Gracia; Isabel Sanjoaquin-Conde; Maria Jose Crusells-Canales; Raquel Fresquet-Molina; Raquel Gracia-Piquer

doi:10.37871/jbres1395

Short Communication

Efficacy and Tolerability of Dolutegravir-Based Dual-Therapies in HIV Naive and Switch Patients

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

News & Press

Publish academic announcements

Share institutional updates, conference announcements, research highlights, and education/science initiatives on JBRES.

Free OptionsSponsored Banner

View Page Submit by Email

Publish Smarter

Quick reasons scholars choose us

Speed + clarity

Decision in 7–14 days

Double-blind review with actionable feedback and clear next steps.

Fast ReviewFair Process

Visibility

DOI + discovery support

Crossref DOI registration and discovery-focused publishing for global reach.

Crossref DOIDiscoverability

Author support

Responsive editorial help

Quick communication, formatting guidance, and proof support until publication.

SupportProof Help

Impact proof

Monthly reach updates

After publishing, we can share visibility signals (views, downloads, discoverability).

Reach ReportMetrics

Trust

Ethical, transparent publishing

Clear policies, COI handling, and publication ethics that protect your work.

EthicsTransparency

Ownership

You keep your rights

Open access publishing with author-friendly licensing and long-term availability.

Author RightsOpen Access

Quality polish

Editing + layout support

Cleaner formatting, better readability, and publication-ready presentation.

EditingProfessional Layout

Time saver

Clear submission guidance

Simple steps, helpful templates, and quick checks to reduce back-and-forth.

Easy SubmitLess Delay

Priority

Returning authors get faster handling

If you’ve published with us, we prioritize communication and processing.

PriorityReturning Authors

Visibility tools

Share-ready links and citations

DOI links, citation-ready details, and share options to amplify your paper.

Citation ReadyShare Tools

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access

Article Type Short Communication

Subject Biology Group

OCLC 9427636899

Jose Manuel Vinuesa-Hernando*, Galadriel Pellejero-Sagastizabal, Mercedes Gimeno-Gracia, Isabel Sanjoaquin-Conde, Maria Jose Crusells-Canales, Raquel Fresquet-Molina and Raquel Gracia-Piquer

Issue: Volume3-Issue12

Pages: 018-019

Received: 2021-12-14

Accepted: 2022-01-10

Published: 2022-01-11

Abstract

Objectives: The introduction of dual-therapy both as preferred starting therapy and in switches has been a revolution, allowing the same efficacy results to be obtained as therapies with more Active Ingredients (AI) with a lower risk of toxicity and interactions. The aim of the study is to analyze the efficacy, tolerability and reasons for switching patients to dolutegravir-based dual therapies.

FullText HTML FullText PDF DOI: 10.37871/jbres1395

Certificate of Publication

Copyright

How to cite this article

Vinuesa-Hernando JM, Pellejero-SagastizÃ¡bal G, Gimeno-Gracia M, Sanjoaquin-Conde I, Crusells-Canales MJ, Fresquet-Molina R, Gracia-Piquer R. Efficacy and Tolerability of Dolutegravir-Based Dual-Therapies in HIV Naive and Switch Patients. J Biomed Res Environ Sci. 2022 Jan 11; 3(1): 018-019. doi: 10.37871/jbres1395, Article ID: JBRES1395, Available at: https://www.jelsciences.com/articles/jbres1395.pdf

Subject area(s)

Toxicology

References

No references available.